You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hematological%20Malignancies

Showing 1 - 25 of 3,813
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CAR-T Treatment for Hematological Malignancies

Recruiting
  • Hematological Malignancies
  • Chimeric Antigen Receptor T-cell Therapy
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Sep 11, 2023

    Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)

    Not yet recruiting
    • Hematological Malignancies
    • Allogeneic T cell progenitors, cultured ex-vivo
    • (no location specified)
    Mar 2, 2023

    Hematologic Malignancy Trial in Tianjin (BR108 injection)

    Recruiting
    • Hematologic Malignancy
    • BR108 injection
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Aug 25, 2023

    Hematological Malignancies Trial in Limoges ("Blend of ginger and lemon essential oils", "Neutral oil")

    Not yet recruiting
    • Hematological Malignancies
    • "Blend of ginger and lemon essential oils", "Neutral oil"
    • Limoges, France
      University Hospital, Limoges
    Nov 20, 2023

    Toxoplasmosis Trial in Sohag (toxoplasma igG)

    Not yet recruiting
    • Toxoplasmosis
    • toxoplasma igG
    • Sohag, Egypt
      Sohag university Hospital
    Jul 19, 2023

    Non-hodgkin's Lymphoma Trial in Beijing (GNC-035)

    Not yet recruiting
    • Non-hodgkin's Lymphoma
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Sep 27, 2023

    Relapsed/Refractory Acute Myeloid Leukemia (AML) Trial in Tianjin (NTQ2494 tablet)

    Recruiting
    • Relapsed/Refractory Acute Myeloid Leukemia (AML)
    • NTQ2494 tablet
    • Tianjin, Tianjin, China
      Hematology Hospital of the Chinese Academy of Medical Sciences
    Sep 17, 2023

    Lymphoma, Leukemia, Myeloma Trial in Tampa (Resistance Training, Aerobic Exercise)

    Recruiting
    • Lymphoma
    • +2 more
    • Resistance Training
    • Aerobic Exercise
    • Tampa, Florida
      Moffitt Cancer Center
    Feb 28, 2023

    Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

    Not yet recruiting
    • Relapsed/Refractory Chronic Lymphocytic Leukemia
    • Tianjin, Tianjin, China
      Institute of Hematology and Blood Diseases Hospital, Chinese Aca
    Jul 13, 2023

    Hematological Malignancy, Solid Tumor Trial (OT-A201, IMids, Bevacizumab)

    Not yet recruiting
    • Hematological Malignancy
    • Solid Tumor
    • (no location specified)
    Apr 24, 2023

    "Don't Eat me" Signal in Hematological Malignancies: CD24 as New

    Recruiting
    • Mantle-cell Lymphoma
    • B Cell Chronic Lymphocytic Leukemia
      • Monza, MB, Italy
        Andrea Aroldi
      May 24, 2023

      Mature B-cell Tumors Trial (Nemtabrutinib)

      Not yet recruiting
      • Mature B-cell Neoplasms
      • (no location specified)
      Jan 13, 2023

      COVID-19 Infection in Hematological Malignancies Patients Trial in Italy

      Recruiting
      • COVID-19 Infection in Hematological Malignancies Patients
        • Brescia, Italy
        • +5 more
        Oct 25, 2022

        Oral Complications in Hematological Malignancies

        Not yet recruiting
        • Hematologic Malignancy
          • Assiut, Egypt
            Assiut university
          Mar 6, 2023

          Hematological Malignancies, Thrombocytopenia Trial in Atlanta, Decatur (EACA, Platelet transfusion)

          Terminated
          Has Results
          • Hematological Malignancies
          • Thrombocytopenia
          • EACA
          • Platelet transfusion
          • Atlanta, Georgia
          • +1 more
          Jun 26, 2022

          Hematological Malignancies Trial (Anti-CD7 CAR-T)

          Not yet recruiting
          • Hematological Malignancies
          • Anti-CD7 CAR-T
          • (no location specified)
          Jul 8, 2022

          Myeloid Hematological Malignancies Trial in Houston (Busulfan, Cyclophosphamide, Fludarabine)

          Completed
          Has Results
          • Myeloid Hematological Malignancies
          • Houston, Texas
            Texas Children's Hospital
          May 13, 2022

          Acute Lymphoblastic Leukemia, Lymphoma, Multiple Myeloma Trial in Taiyuan (CAR-T Autologous T cell injection)

          Recruiting
          • Acute Lymphoblastic Leukemia
          • +2 more
          • CAR-T Autologous T cell injection
          • Taiyuan, Shanxi, China
            Shanxi Bethune Hospital
          Dec 2, 2022

          Hematological Malignancy, COVID-19 Trial in Beijing (Anti-COVID-19 Antibody SA55 for Injection)

          Recruiting
          • Hematological Malignancy
          • COVID-19
          • Anti-COVID-19 Antibody SA55 for Injection
          • Beijing, Beijing, China
            Beijing Boren Hospital
          Jan 9, 2023

          Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

          Not yet recruiting
          • Acute Lymphoblastic Leukemia, in Relapse
          • +4 more
          • Utrecht, Netherlands
            Princess Máxima Center for Pediatric Oncology
          Feb 22, 2023

          Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic

          Not yet recruiting
          • Acute Lymphoblastic Leukemia
          • +4 more
          • Utrecht, Netherlands
            Princess Máxima Center for Pediatric Oncology
          Feb 20, 2023

          Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

          Not yet recruiting
          • Acute Lymphoblastic Leukemia, in Relapse
          • +4 more
          • Utrecht, Netherlands
            Princess Máxima Center for Pediatric Oncology
          Feb 16, 2023

          Secondary Antibody Deficiency Trial (Immunoglobulin replacement therapy (IGRT))

          Not yet recruiting
          • Secondary Antibody Deficiency
          • Immunoglobulin replacement therapy (IGRT)
          • (no location specified)
          Nov 4, 2022

          Tumors, Hematologic Tumors, Tumors by Site Trial in Wuhan (RD13-02 cell infusion)

          Recruiting
          • Neoplasms
          • +3 more
          • RD13-02 cell infusion
          • Wuhan, Hubei, China
            Union Hospital, Huazhong University of Science and Technology
          Jun 8, 2023

          Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

          Recruiting
          • Hematopoietic Malignancy
          • +2 more
          • Umbilical Cord Blood Transplantation
          • Suzhou, Jiangsu, China
            The First Affiliated Hospital of Soochow university
          Nov 6, 2023